Clinical trial

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

NCT00030602

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-01-01

PhasePHASE2

Study timeline

Study start (actual)2000-01-01Date precision: month

Registry last updated2019-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PSA prostate cancer vaccineBIOLOGICAL

incomplete Freund's adjuvantBIOLOGICAL

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00030602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.